Thermo Fisher Scientific Inc. (TMO)
NYSE · Healthcare · Medical - Diagnostics & Research
Profile
Thermo Fisher Scientific Inc.
- Exchange
- NYSE
- Ticker
- TMO
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Key facts
Thermo Fisher Scientific Inc.: key facts
- Thermo Fisher Scientific Inc. (NYSE: TMO) is a Medical - Diagnostics & Research company in the Healthcare sector.
- In fiscal 2025, Thermo Fisher Scientific Inc. reported revenue of $44.6B and net income of $6.7B.
- Revenue grew 3.2% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $47.4B and net income was $7.1B.
MonkScore
Thermo Fisher Scientific Inc.'s MonkScore
MonkScore
MonkScore range: 60–70
as of October 2026
Sector rank: 252 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth40–50
- Profitability50–60
- Quality60–70
- Market Conviction80–90
- Safety20–30
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Thermo Fisher Scientific Inc.'s annual figures and the last twelve months, in USD. Last report: 26 September 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $47.4B | $44.6B | $42.9B | $42.9B | $44.9B | $39.2B |
| Gross profit | $19.6B | $18.2B | $17.7B | $17.2B | $19.0B | $19.6B |
| Operating income | $8.5B | $8.1B | $7.7B | $7.4B | $8.5B | $10.3B |
| Net income | $7.1B | $6.7B | $6.3B | $6.0B | $7.0B | $7.7B |
| Operating cash flow | $9.3B | $7.8B | $8.7B | $8.4B | $9.2B | $9.5B |
| Capital expenditure | -$1.7B | -$1.5B | -$1.4B | -$1.5B | -$2.2B | -$2.5B |
| Free cash flow | $7.6B | $6.3B | $7.3B | $6.9B | $6.9B | $7.0B |
| Total debt | $41.4B | $39.4B | $32.8B | $36.4B | $36.1B | $36.3B |
| Cash | $5.5B | $9.9B | $4.0B | $8.1B | $8.5B | $4.5B |
Revenue growth a year
- 1-year
- 3.9%
- 3-year
- -0.3%
- 4-year
- 3.2%
Compound growth between fiscal years.
Peers
Similar companies
- Natera, Inc.NASDAQ:NTRAMonkScore range: 70–80
- Quest Diagnostics IncorporatedNYSE:DGXMonkScore range: 70–80
- Sotera Health CompanyNASDAQ:SHCMonkScore range: 70–80
- IQVIA Holdings Inc.NYSE:IQVMonkScore range: 70–80
- Agilent Technologies, Inc.NYSE:AMonkScore range: 70–80
- Mettler-Toledo International Inc.NYSE:MTDMonkScore range: 90–100
- Illumina, Inc.NASDAQ:ILMNMonkScore range: 90–100
- CareDx, IncNASDAQ:CDNAMonkScore range: 90–100
Compare
Compare with
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.